Molecular Background of Estrogen Receptor Gene Expression in Endometriotic Cells

Abstract

The molecular background of estrogen receptor (ER) expression is important to understand the pathophysiology of the high estrogen environment in endometriosis. However, the molecular details have not been fully understood. The objective of this study is to evaluate the molecular background of ERα and ERβ messenger RNA (mRNA) expression in endometriotic cells. The following summarizes our observations: (1) ERα mRNA expression in endometriotic cells was estimated to be approximately one-tenth of that in endometrial cells. (2) Three mRNAs, which include 3 different 5′-untranslated exons tagged to an open reading frame of wild-type ERα, were detected. (3) Expression of ERβ mRNA depends mostly on 0N promoter and includes 2 open reading frames: one for a wild-type ERβ1 and another for a splice variant ERβ2. (4) Expression of ERβ1 mRNA was approximately 40-fold higher than that in endometrial cells. (5) Expression of ERβ2 mRNA was almost at a comparable level of the ERβ1. 9 (6) ERα and ERβ mRNAs are equivalently expressed in endometriotic cells. These observations show the molecular background of ER mRNA expression in endometriotic cells and provide a clue to further understanding the estrogen-dependent pathophysiology leading to clinical application in endometriosis.

Keywords

estrogen receptor α estrogen receptor β mRNA expression endometriosis

Get full access to this article

View all access options for this article.

References

Izawa

Harada

Taniguchi

Ohama

Takenaka

Terakawa

. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil Steril. 2008;89(suppl 5):1390–1396.

Izawa

Taniguchi

Uegaki

. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril. 2011;95(1):33–39.

Olive

Pritts

. Treatment of endometriosis. N Engl J Med. 2001;345(4):266–275.

Brandenberger

Lebovic

Tee

. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod. 1999;5(7):651–655.

Fujimoto

Hirose

Sakaguchi

Tamaya

. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod. 1999;5(8):742–747.

Matsuzaki

Fukaya

Uehara

Murakami

Sasano

Yajima

. Characterization of messenger RNA expression of estrogen receptor-alpha and -beta in patients with ovarian endometriosis. Fertil Steril. 2000;73(6):1219–1225.

Xue

Lin

Cheng

. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687.

Harris

. The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents? Nucl Recept Signal. 2006;4:e012.

Xing

Feng

Miller

. Estrogen modulates TNF-alpha-induced inflammatory responses in rat aortic smooth muscle cells through estrogen receptor-beta activation. Am J Physiol Heart Circ Physiol. 2007;292(6):H2607–H2612.

10.

Moore

McKee

Slentz-Kesler

. Cloning and characterization of human estrogen receptor beta isoforms. Biochemical and Biophysical Research Communications. 1998;247(1):75–78.

11.

Leung

Mak

Hassan

. Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling. PNAS. 2006;103(35):13162–13167.

12.

Paulmurugan

Tamrazi

Massoud

Katzenellenbogen

Gambhir

. In vitro and in vivo molecular imaging of estrogen receptor alpha and beta homo- and heterodimerization: exploration of new modes of receptor regulation. Mol Endocrinol. 2011;25(12):2029–2040.

13.

Chakraborty

Willett

Biswas

. Insight into estrogen receptor beta-beta and alpha-beta homo- and heterodimerization: a combined molecular dynamics and sequence analysis study. Biophys Chem. 2012;170:42–50.

14.

Iwabe

Harada

Tsudo

. Tumor necrosis factor-alpha promotes proliferation of endometriotic stromal cells by inducing interleukin-8 gene and protein expression. J Clin Endocrinol Metab. 2000;85(2):824–829.

15.

Sakamoto

Harada

Horie

. Tumor necrosis factor-alpha-induced interleukin-8 (IL-8) expression in endometriotic stromal cells, probably through nuclear factor-kappa B activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab. 2003;88(2):730–735.

16.

Izawa

Harada

Deura

Taniguchi

Iwabe

Terakawa

. Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells. Hum Reprod. 2006;21(3):600–604.

17.

Figtree

McDonald

Watkins

Channon

. Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation. 2003;107(1):120–126.

18.

Suzuki

Akahira

Miura

. Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5’-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 2008;99(12):2365–2372.

19.

Powell

Shanle

Brinkman

. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERalpha and ERbeta. PLoS One. 2012;7(2):e30993.

20.

Lindberg

Moverare

Skrtic

. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol. 2003;17(2):203–208.

21.

Saji

Hirose

Toi

. Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother Pharmacol. 2005;56(suppl 1):21–26.

22.

Pettersson

Grandien

Kuiper

Gustafsson

. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol Endocrinol. 1997;11(10):1486–1496.

23.

Tremblay

Labrie

Giguere

. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol. 1999;19(3):1919–1927.

24.

Paterni

Granchi

Katzenellenbogen

Minutolo

. Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential. Steroids. 2014;90:13–29.

25.

Monsivais

Dyson

Yin

. ERβ- and prostaglandin E2-regulated pathways integrate cell proliferation via Ras-like and estrogen-regulated growth inhibitor in endometriosis. Mol Endocrinol. 2014;28(8):1304–1315.